Tobramycin Solution
Product Images NDC 68180-962

25 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 68180-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 01)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 01)
Chemical structure of Tobramycin, showing its molecular components and arrangement as represented in the diagram.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 02)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 02)
A line graph titled 'Relative Change From Baseline in FEV1 % Predicted' depicting average relative change in FEV1 percentage predicted over 24 weeks. It compares four groups: two studies each of Tobramycin Inhalation Solution and placebo, showing a positive increase for Tobramycin groups and stable or negative change for placebo groups over time.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 03)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 03)
Line graph titled 'Absolute Change From Baseline in Log10 CFUs' showing average change of Log10 colony-forming units (CFUs) over weeks for four groups: Study 1 Placebo, Study 2 Placebo, Study 1 Tobramycin Inhalation Solution, and Study 2 Tobramycin Inhalation Solution. The x-axis represents weeks (0 to 24), and the y-axis shows average change in Log10 CFUs ranging from -2.2 to 0.6. Data points indicate fluctuations in CFU levels over time, with periods labeled 'on drug' at weeks 0-4, 8-12, and 16-20.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 04)

FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 05)

FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 06)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 06)
Instructional diagram of a respiratory inhalation nebulizer assembly including labeled components: air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, tubing, and clean paper or cloth towels. The image shows how the parts connect to facilitate inhalation therapy.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 07)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 07)
Illustration showing two hands holding Tobramycin Inhalation Solution, USP 300 mg/5 mL ampules. The diagram indicates a twisting or snapping motion between the tops of the two ampules, likely demonstrating how to open the ampules for respiratory inhalation use.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 08)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 08)
An illustration labeled as Figure C showing a single-dose ampule for inhalation solution with the label "LUPIN" on the body of the ampule. An arrow points to the top left side indicating the location of the Expiration Date on the ampule.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 09)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 09)
An instructional diagram showing assembly of a respiratory nebulizer for Tobramycin solution. The image depicts hands attaching the nebulizer top to the nebulizer cup, with the mouthpiece, tubing, and inspiratory valve cap labeled and displayed around the cup.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 10)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 10)
An instructional diagram labeled Figure E showing hands assembling a nebulizer device. It illustrates the insertion and twisting action of the nebulizer insert into the nebulizer cup, with directional arrows indicating how to place the top part of the insert into the cup.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 11)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 11)
Illustration labeled as Figure F showing components of a nebulizer. The image depicts a nebulizer cup with a handle on the right and a separate top piece on the left, both placed on clean paper or cloth towels. The nebulizer cup is cylindrical with a side outlet, and the top piece is designed to fit onto the cup.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 12)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 12)
An instructional diagram labeled Figure G showing a hand opening the front flap of a device labeled Pulmo-Aide, likely demonstrating how to access or use the device related to inhalation therapy.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 13)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 13)
An instructional illustration showing a hand plugging an electrical plug into a two-socket wall outlet. The image highlights the motion of insertion with an arrow pointing toward the outlet, indicating connection of the plug to the power source.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 14)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 14)
An instructional illustration depicting hands holding a Tobramycin inhalation solution ampule. The ampule is labeled with its strength, 300 mg/5 mL, and the image highlights the 'Bottom Tab' with an arrow and a curved arrow indicating the direction to snap or open the ampule for use.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 15)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 15)
An instructional illustration (Figure J) showing a hand holding a vial or ampule and dispensing a liquid drop into a respiratory inhalation device. The inhaler device is depicted with a mouthpiece and a chamber for the liquid medication.*
FDA Label Image

Figure K (E6e150b5 807d 425e 96f8 345c2a56ee8e 16)

Figure K (E6e150b5 807d 425e 96f8 345c2a56ee8e 16)
An instructional diagram labeled Figure K illustrating the parts of a nebulizer used in inhalation therapy. It shows the nebulizer top, stem, semi-circle, nebulizer cup, and nebulizer outlet, with an arrow indicating how the top piece fits onto the cup by twisting.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 17)

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 17)
An instructional diagram showing the assembly of a nebulizer for inhalation solution use. It illustrates the connection of the mouthpiece to the nebulizer outlet on the nebulizer cup. Labels identify each part to guide proper attachment.*
FDA Label Image

Figure M (E6e150b5 807d 425e 96f8 345c2a56ee8e 18)

Figure M (E6e150b5 807d 425e 96f8 345c2a56ee8e 18)
An instructional illustration labeled Figure M showing the assembly of an inspiratory valve cap onto a respiratory inhalation device. The diagram uses arrows to indicate the placement of the valve cap on the device, typically used for inhalation of the Tobramycin solution.*
FDA Label Image

Figure N (E6e150b5 807d 425e 96f8 345c2a56ee8e 19)

Figure N (E6e150b5 807d 425e 96f8 345c2a56ee8e 19)
An instructional diagram labeled Figure N, showing a respiratory inhalation device with a handle and an air intake labeled on the side. Arrows indicate how to connect a component, likely a tube or mouthpiece, to the bottom of the inhaler.*
FDA Label Image

Figure O (E6e150b5 807d 425e 96f8 345c2a56ee8e 20)

Figure O (E6e150b5 807d 425e 96f8 345c2a56ee8e 20)
An instructional line drawing showing a hand pressing a button or lever on a device labeled 'Pulmo-Aide'. The device appears to be a nebulizer or inhalation aid with a row of circular elements along the front.*
FDA Label Image

Figure P (E6e150b5 807d 425e 96f8 345c2a56ee8e 21)

Figure P (E6e150b5 807d 425e 96f8 345c2a56ee8e 21)
An instructional diagram labeled Figure P showing a nebulizer device with mist coming out from its mouthpiece. The nebulizer features a container with a handle and tubing at the bottom for respiratory inhalation therapy.*
FDA Label Image

Figure Q (E6e150b5 807d 425e 96f8 345c2a56ee8e 22)

Figure Q (E6e150b5 807d 425e 96f8 345c2a56ee8e 22)
Instructional diagram showing a person using a respiratory inhalation device with a mouthpiece and a nose clip. The person has the mouthpiece in their mouth and the nose clip positioned on their nose, demonstrating correct inhalation technique for Tobramycin inhalation solution.*
FDA Label Image

Image (E6e150b5 807d 425e 96f8 345c2a56ee8e 23)

FDA Label Image

Pouch (E6e150b5 807d 425e 96f8 345c2a56ee8e 24)

Pouch (E6e150b5 807d 425e 96f8 345c2a56ee8e 24)
Label for Tobramycin Inhalation Solution USP 300 mg/5 mL ampules by Lupin Pharmaceuticals, Inc. The label indicates it is a respiratory inhalation solution, packaged as 4 single-dose 5 mL ampules. The label includes storage instructions to refrigerate, usage details for nebulizer administration, and contains no preservatives. The NDC code visible is 68180-962-04.*
FDA Label Image

Carton (E6e150b5 807d 425e 96f8 345c2a56ee8e 25)

Carton (E6e150b5 807d 425e 96f8 345c2a56ee8e 25)
Packaging label for Tobramycin Inhalation Solution, USP 300 mg/5 mL ampules by Lupin Pharmaceuticals, Inc. The carton contains 56 single-dose ampules, a 28-day supply, for inhalation only by nebulizer. The label advises storing the product in a refrigerator and notes it contains no preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.